{"count": 6, "results": [{"_id": "34311387", "pmid": 34311387, "title": "Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers.", "journal": "Curr Opin Pharmacol", "authors": ["León-González AJ", "Jiménez-Vacas JM", "Fuentes-Fayos AC", "Sarmento-Cabral A", "Herrera-Martínez AD", "Gahete MD", "Luque RM"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.coph.2021.06.002", "meta_date_publication": "2021 Oct", "meta_volume": "60", "meta_issue": "", "meta_pages": "17-26", "score": 50282.234, "text_hl": "Role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and other metabolic drugs in the prevention and therapy of @<m>DISEASE_Endocrine_Gland_Neoplasms</m> @DISEASE_MESH:D004701 @@@endocrine-related cancers@@@.", "citations": {"NLM": "León-González AJ, Jiménez-Vacas JM, Fuentes-Fayos AC, Sarmento-Cabral A, Herrera-Martínez AD, Gahete MD, Luque RM. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers. Curr Opin Pharmacol. 2021 Oct;60():17-26. PMID: 34311387", "BibTeX": "@article{34311387, title={Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers.}, author={León-González AJ and Jiménez-Vacas JM and Fuentes-Fayos AC and Sarmento-Cabral A and Herrera-Martínez AD and Gahete MD and Luque RM}, journal={Curr Opin Pharmacol}, volume={60}, pages={17-26}}"}}, {"_id": "33713207", "pmid": 33713207, "pmcid": "PMC8134278", "title": "The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin", "journal": "Int J Clin Oncol", "authors": ["Costa D", "Ceccato F", "Lauretta R", "Mercuri V", "D'Amico T", "De Vito C", "Scaroni C", "Appetecchia M", "Gargiulo P"], "date": "2021-06-01T00:00:00Z", "doi": "10.1007/s10147-021-01895-y", "meta_date_publication": "2021 Jun", "meta_volume": "26", "meta_issue": "6", "meta_pages": "1015-1021", "score": 50261.223, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@ has a mitogenic effect through its interaction with the @GENE_IGF1R @GENE_3480 @@@IGF-1 receptor@@@ (@GENE_IGF1R @GENE_3480 @@@IGF-1R@@@) that also binds @GENE_IGF1 @GENE_3479 @@@IGF-1@@@. On the other hand, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an anti-@DISEASE_Hyperglycemic_Hyperosmolar_Nonketotic_Coma @DISEASE_MESH:D006944 @@@hyperglycemic@@@ drug that decreases serum levels of @GENE_INS @GENE_3630 @@@insulin@@@ and @GENE_IGF1 @GENE_3479 @@@IGF-1@@@, could have a protective role in the treatment of @<m>DISEASE_Endocrine_Gland_Neoplasms</m> @DISEASE_MESH:D004701 @@@endocrine tumors@@@.", "citations": {"NLM": "Costa D, Ceccato F, Lauretta R, Mercuri V, D'Amico T, De Vito C, Scaroni C, Appetecchia M, Gargiulo P. The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin Int J Clin Oncol. 2021 Jun;26(6):1015-1021. PMID: 33713207", "BibTeX": "@article{33713207, title={The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin}, author={Costa D and Ceccato F and Lauretta R and Mercuri V and D'Amico T and De Vito C and Scaroni C and Appetecchia M and Gargiulo P}, journal={Int J Clin Oncol}, volume={26}, number={6}, pages={1015-1021}}"}}, {"_id": "34884872", "pmid": 34884872, "pmcid": "PMC8658259", "title": "Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area", "journal": "Int J Mol Sci", "authors": ["Tulipano G"], "date": "2021-12-02T00:00:00Z", "doi": "10.3390/ijms222313068", "meta_date_publication": "2021 Dec 2", "meta_volume": "22", "meta_issue": "23", "meta_pages": "", "score": 50250.508, "text_hl": "Recent evidence either supporting or challenging the potential use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to treat @<m>DISEASE_Endocrine_Gland_Neoplasms</m> @DISEASE_MESH:D004701 @@@endocrine tumors@@@ is discussed. ", "citations": {"NLM": "Tulipano G. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area Int J Mol Sci. 2021 Dec 2;22(23):. PMID: 34884872", "BibTeX": "@article{34884872, title={Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area}, author={Tulipano G}, journal={Int J Mol Sci}, volume={22}, number={23}}"}}, {"_id": "39941109", "pmid": 39941109, "title": "Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer.", "journal": "Int J Mol Sci", "authors": ["Porcel-Pastrana F", "Montero-Hidalgo AJ", "G-García ME", "Gil-Duque I", "Prats-Escribano A", "Gahete MD", "Sarmento-Cabral A", "Luque RM", "León-González AJ"], "date": "2025-02-05T00:00:00Z", "doi": "10.3390/ijms26031341", "meta_date_publication": "2025 Feb 5", "meta_volume": "26", "meta_issue": "3", "meta_pages": "", "score": 50249.957, "text_hl": "Hence, some metabolic drugs like @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ have emerged as potential anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ agents against several @<m>DISEASE_Endocrine_Gland_Neoplasms</m> @DISEASE_MESH:D004701 @@@endocrine-related cancers@@@. ", "citations": {"NLM": "Porcel-Pastrana F, Montero-Hidalgo AJ, G-García ME, Gil-Duque I, Prats-Escribano A, Gahete MD, Sarmento-Cabral A, Luque RM, León-González AJ. Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer. Int J Mol Sci. 2025 Feb 5;26(3):. PMID: 39941109", "BibTeX": "@article{39941109, title={Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer.}, author={Porcel-Pastrana F and Montero-Hidalgo AJ and G-García ME and Gil-Duque I and Prats-Escribano A and Gahete MD and Sarmento-Cabral A and Luque RM and León-González AJ}, journal={Int J Mol Sci}, volume={26}, number={3}}"}}, {"_id": "31307011", "pmid": 31307011, "title": "The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.", "journal": "J Mol Endocrinol", "authors": ["Thakur S", "Daley B", "Klubo-Gwiezdzinska J"], "date": "2019-08-01T00:00:00Z", "doi": "10.1530/JME-19-0083", "meta_date_publication": "2019 Aug", "meta_volume": "63", "meta_issue": "2", "meta_pages": "R17-R35", "score": 50079.688, "text_hl": "The role of an anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic drug@@@ @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @<m>DISEASE_Endocrine_Gland_Neoplasms</m> @DISEASE_MESH:D004701 @@@endocrine tumors@@@.", "citations": {"NLM": "Thakur S, Daley B, Klubo-Gwiezdzinska J. The role of an anti-diabetic drug metformin in the treatment of endocrine tumors. J Mol Endocrinol. 2019 Aug;63(2):R17-R35. PMID: 31307011", "BibTeX": "@article{31307011, title={The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.}, author={Thakur S and Daley B and Klubo-Gwiezdzinska J}, journal={J Mol Endocrinol}, volume={63}, number={2}, pages={R17-R35}}"}}, {"_id": "22801104", "pmid": 22801104, "title": "Endocrine-related cancers and the role of AMPK.", "journal": "Mol Cell Endocrinol", "authors": ["Brown KA", "Samarajeewa NU", "Simpson ER"], "date": "2013-02-25T00:00:00Z", "doi": "10.1016/j.mce.2012.06.016", "meta_date_publication": "2013 Feb 25", "meta_volume": "366", "meta_issue": "2", "meta_pages": "170-9", "score": 50070.65, "text_hl": "This review also presents data relating to the role of @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@ in @DISEASE_Ovarian_Neoplasms @DISEASE_MESH:D010051 @@@cancers of the endometrium, ovary and colon@@@, and discusses the possible use of @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@-activating drugs including @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for the treatment of all @<m>DISEASE_Endocrine_Gland_Neoplasms</m> @DISEASE_MESH:D004701 @@@endocrine-related cancers@@@.", "citations": {"NLM": "Brown KA, Samarajeewa NU, Simpson ER. Endocrine-related cancers and the role of AMPK. Mol Cell Endocrinol. 2013 Feb 25;366(2):170-9. PMID: 22801104", "BibTeX": "@article{22801104, title={Endocrine-related cancers and the role of AMPK.}, author={Brown KA and Samarajeewa NU and Simpson ER}, journal={Mol Cell Endocrinol}, volume={366}, number={2}, pages={170-9}}"}}]}